M&A Corner
Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition.18 Dec 2023
Pfizer’s exclusive license agreement with Nona Biosciences focuses on developing HBM9033, a mesothelin-targeting antibody-drug conjugate for solid tumors. Pfizer commits... Continue Reading
|
Lunit Acquires AI-Enabled Breast Cancer Detection Platform Volpara for $193M.18 Dec 2023
Lunit, a South Korean AI leader, aims to acquire Volpara, a global pioneer in AI-driven cancer detection, in a landmark... Continue Reading
|
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company18 Dec 2023
Aeterna Zentaris Inc. and Ceapro Inc. plan an all-stock merger, forming a Nasdaq and TSX-listed entity in early 2024. Aimed... Continue Reading
|
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease18 Dec 2023
Roivant completed the acquisition by Roche of Telavant for $7.1 billion. Telavant owns RVT-3101, a therapy for inflammatory bowel disease.... Continue Reading
|
Rain Oncology Enters into an Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights18 Dec 2023
Rain Oncology Inc. agreed to be acquired by Pathos AI, Inc. for $1.16 per share in cash plus a contingent... Continue Reading
|
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies18 Dec 2023
Certara, Inc. has acquired Applied BioMath to fortify their position in model-informed drug discovery and development. Combining their expertise in... Continue Reading
|
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®18 Dec 2023
Integra LifeSciences is set to acquire Acclarent from Ethicon, a Johnson & Johnson MedTech company, for $275 million in cash,... Continue Reading
|
PharmaDrug CEO Provides Vision for Securedose Acquisition18 Dec 2023
PharmaDrug Inc. updates on the acquisition of SecureDose, focusing on developing synthetic drug formulations for potential drug policy reform waves.... Continue Reading
|
BioVaxys in Non-Binding Discussions for Major Immuno therapeutics Technology Acquisition18 Dec 2023
BioVaxys Technology Corp. is in non-binding talks to acquire an immunotherapeutics IP portfolio in oncology and immunology from a biotech... Continue Reading
|
Jakarta-Based Digital Clinic Obtains $5M and More Digital Health Fundings.18 Dec 2023
Klinik Pintar secures $5M in Series A extension led by Altara Ventures, aiming to expand its digital clinic network and... Continue Reading
|